Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India’s Drug Watchdog DCGI Speeds Up Regulatory Overhaul; Single Window Clearance to Precede Central Drug Authority

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - India's drug regulatory body, the Drug Controller General of India, is set for a comprehensive overhaul of its regulatory and administrative functions

You may also be interested in...



M K Bhan, Secretary To India’s Department Of Biotechnology On Creating Indian Biopolis Akin To Singapore: An Interview With PharmAsia News

Dr. Maharaj Kishan Bhan, secretary to the department of biotechnology, government of India, is perhaps the best known biotechnology scientist in the country. He is also known to have connected science and technology with the primary healthcare needs of India's rural population through many programs. Bestowed with a number of responsibilities, Bhan tells PharmAsia News he is working on a plan to change the Indian biotechnology landscape.

M K Bhan, Secretary To India’s Department Of Biotechnology On Creating Indian Biopolis Akin To Singapore: An Interview With PharmAsia News

Dr. Maharaj Kishan Bhan, secretary to the department of biotechnology, government of India, is perhaps the best known biotechnology scientist in the country. He is also known to have connected science and technology with the primary healthcare needs of India's rural population through many programs. Bestowed with a number of responsibilities, Bhan tells PharmAsia News he is working on a plan to change the Indian biotechnology landscape.

India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted

Disseminated power appears to be the goal, but would the system require four times the paperwork?

Related Content

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel